Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04830592 |
Title | A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck (MOAT) |
Acronym | MOAT |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | PsiOxus Therapeutics Ltd |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | GBR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Cardiff & Vale University LHB | Cardiff | United Kingdom | Details | |||
The Clatterbridge Cancer Centre | Liverpool | United Kingdom | Details | |||
The Royal Marsden Hospital | London | United Kingdom | Details | |||
University Hospital Southampton NHS Foundation Trust | Southampton | SO16 6YD | United Kingdom | Details |